Global Mepivacaine Hydrochloride Injection Market Research Report 2025

Publication ID:

PB504254932

Publication Date:

April 16, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

The global market for Mepivacaine Hydrochloride Injection was valued at US$ 146 million in the year 2024 and is projected to reach a revised size of US$ 194 million by 2031, growing at a CAGR of 4.0% during the forecast period.
Mepivacaine听is indicated for production of local anesthesia for dental procedures听by infiltration or nerve block in adults and pediatric patients.
North American market for Mepivacaine Hydrochloride Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Mepivacaine Hydrochloride Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Mepivacaine Hydrochloride Injection include Pfizer, Septodont, Fresenius Kabi, Cisen Pharmaceutical, Shandong Hualu Pharmaceutical, Reyoung Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Mepivacaine Hydrochloride Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mepivacaine Hydrochloride Injection.
The Mepivacaine Hydrochloride Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Mepivacaine Hydrochloride Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mepivacaine Hydrochloride Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Pfizer
Septodont
Fresenius Kabi
Cisen Pharmaceutical
Shandong Hualu Pharmaceutical
Reyoung Pharmaceutical
Segment by Type
1%
2%
Others
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Mepivacaine Hydrochloride Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Mepivacaine Hydrochloride Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Mepivacaine Hydrochloride Injection Market Overview
1.1 Product Definition
1.2 Mepivacaine Hydrochloride Injection by Type
1.2.1 Global Mepivacaine Hydrochloride Injection Market Value Comparison by Type (2024 VS 2031)
1.2.2 1%
1.2.3 2%
1.2.4 Others
1.3 Mepivacaine Hydrochloride Injection by Application
1.3.1 Global Mepivacaine Hydrochloride Injection Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Mepivacaine Hydrochloride Injection Market Size Estimates and Forecasts
1.4.1 Global Mepivacaine Hydrochloride Injection Revenue 2020-2031
1.4.2 Global Mepivacaine Hydrochloride Injection Sales 2020-2031
1.4.3 Global Mepivacaine Hydrochloride Injection Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Mepivacaine Hydrochloride Injection Market Competition by Manufacturers
2.1 Global Mepivacaine Hydrochloride Injection Sales Market Share by Manufacturers (2020-2025)
2.2 Global Mepivacaine Hydrochloride Injection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Mepivacaine Hydrochloride Injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Mepivacaine Hydrochloride Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Mepivacaine Hydrochloride Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Mepivacaine Hydrochloride Injection, Product Type & Application
2.7 Global Key Manufacturers of Mepivacaine Hydrochloride Injection, Date of Enter into This Industry
2.8 Global Mepivacaine Hydrochloride Injection Market Competitive Situation and Trends
2.8.1 Global Mepivacaine Hydrochloride Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Mepivacaine Hydrochloride Injection Players Market Share by Revenue
2.8.3 Global Mepivacaine Hydrochloride Injection Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Mepivacaine Hydrochloride Injection Market Scenario by Region
3.1 Global Mepivacaine Hydrochloride Injection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Mepivacaine Hydrochloride Injection Sales by Region: 2020-2031
3.2.1 Global Mepivacaine Hydrochloride Injection Sales by Region: 2020-2025
3.2.2 Global Mepivacaine Hydrochloride Injection Sales by Region: 2026-2031
3.3 Global Mepivacaine Hydrochloride Injection Revenue by Region: 2020-2031
3.3.1 Global Mepivacaine Hydrochloride Injection Revenue by Region: 2020-2025
3.3.2 Global Mepivacaine Hydrochloride Injection Revenue by Region: 2026-2031
3.4 North America Mepivacaine Hydrochloride Injection Market Facts & Figures by Country
3.4.1 North America Mepivacaine Hydrochloride Injection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Mepivacaine Hydrochloride Injection Sales by Country (2020-2031)
3.4.3 North America Mepivacaine Hydrochloride Injection Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Mepivacaine Hydrochloride Injection Market Facts & Figures by Country
3.5.1 Europe Mepivacaine Hydrochloride Injection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Mepivacaine Hydrochloride Injection Sales by Country (2020-2031)
3.5.3 Europe Mepivacaine Hydrochloride Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Mepivacaine Hydrochloride Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Mepivacaine Hydrochloride Injection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Mepivacaine Hydrochloride Injection Sales by Region (2020-2031)
3.6.3 Asia Pacific Mepivacaine Hydrochloride Injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Mepivacaine Hydrochloride Injection Market Facts & Figures by Country
3.7.1 Latin America Mepivacaine Hydrochloride Injection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Mepivacaine Hydrochloride Injection Sales by Country (2020-2031)
3.7.3 Latin America Mepivacaine Hydrochloride Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Mepivacaine Hydrochloride Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Mepivacaine Hydrochloride Injection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Mepivacaine Hydrochloride Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Mepivacaine Hydrochloride Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Mepivacaine Hydrochloride Injection Sales by Type (2020-2031)
4.1.1 Global Mepivacaine Hydrochloride Injection Sales by Type (2020-2025)
4.1.2 Global Mepivacaine Hydrochloride Injection Sales by Type (2026-2031)
4.1.3 Global Mepivacaine Hydrochloride Injection Sales Market Share by Type (2020-2031)
4.2 Global Mepivacaine Hydrochloride Injection Revenue by Type (2020-2031)
4.2.1 Global Mepivacaine Hydrochloride Injection Revenue by Type (2020-2025)
4.2.2 Global Mepivacaine Hydrochloride Injection Revenue by Type (2026-2031)
4.2.3 Global Mepivacaine Hydrochloride Injection Revenue Market Share by Type (2020-2031)
4.3 Global Mepivacaine Hydrochloride Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Mepivacaine Hydrochloride Injection Sales by Application (2020-2031)
5.1.1 Global Mepivacaine Hydrochloride Injection Sales by Application (2020-2025)
5.1.2 Global Mepivacaine Hydrochloride Injection Sales by Application (2026-2031)
5.1.3 Global Mepivacaine Hydrochloride Injection Sales Market Share by Application (2020-2031)
5.2 Global Mepivacaine Hydrochloride Injection Revenue by Application (2020-2031)
5.2.1 Global Mepivacaine Hydrochloride Injection Revenue by Application (2020-2025)
5.2.2 Global Mepivacaine Hydrochloride Injection Revenue by Application (2026-2031)
5.2.3 Global Mepivacaine Hydrochloride Injection Revenue Market Share by Application (2020-2031)
5.3 Global Mepivacaine Hydrochloride Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Mepivacaine Hydrochloride Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer Mepivacaine Hydrochloride Injection Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Septodont
6.2.1 Septodont Company Information
6.2.2 Septodont Description and Business Overview
6.2.3 Septodont Mepivacaine Hydrochloride Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Septodont Mepivacaine Hydrochloride Injection Product Portfolio
6.2.5 Septodont Recent Developments/Updates
6.3 Fresenius Kabi
6.3.1 Fresenius Kabi Company Information
6.3.2 Fresenius Kabi Description and Business Overview
6.3.3 Fresenius Kabi Mepivacaine Hydrochloride Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Fresenius Kabi Mepivacaine Hydrochloride Injection Product Portfolio
6.3.5 Fresenius Kabi Recent Developments/Updates
6.4 Cisen Pharmaceutical
6.4.1 Cisen Pharmaceutical Company Information
6.4.2 Cisen Pharmaceutical Description and Business Overview
6.4.3 Cisen Pharmaceutical Mepivacaine Hydrochloride Injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Cisen Pharmaceutical Mepivacaine Hydrochloride Injection Product Portfolio
6.4.5 Cisen Pharmaceutical Recent Developments/Updates
6.5 Shandong Hualu Pharmaceutical
6.5.1 Shandong Hualu Pharmaceutical Company Information
6.5.2 Shandong Hualu Pharmaceutical Description and Business Overview
6.5.3 Shandong Hualu Pharmaceutical Mepivacaine Hydrochloride Injection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Shandong Hualu Pharmaceutical Mepivacaine Hydrochloride Injection Product Portfolio
6.5.5 Shandong Hualu Pharmaceutical Recent Developments/Updates
6.6 Reyoung Pharmaceutical
6.6.1 Reyoung Pharmaceutical Company Information
6.6.2 Reyoung Pharmaceutical Description and Business Overview
6.6.3 Reyoung Pharmaceutical Mepivacaine Hydrochloride Injection Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Reyoung Pharmaceutical Mepivacaine Hydrochloride Injection Product Portfolio
6.6.5 Reyoung Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Mepivacaine Hydrochloride Injection Industry Chain Analysis
7.2 Mepivacaine Hydrochloride Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Mepivacaine Hydrochloride Injection Production Mode & Process Analysis
7.4 Mepivacaine Hydrochloride Injection Sales and Marketing
7.4.1 Mepivacaine Hydrochloride Injection Sales Channels
7.4.2 Mepivacaine Hydrochloride Injection Distributors
7.5 Mepivacaine Hydrochloride Injection Customer Analysis
8 Mepivacaine Hydrochloride Injection Market Dynamics
8.1 Mepivacaine Hydrochloride Injection Industry Trends
8.2 Mepivacaine Hydrochloride Injection Market Drivers
8.3 Mepivacaine Hydrochloride Injection Market Challenges
8.4 Mepivacaine Hydrochloride Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Pfizer
Septodont
Fresenius Kabi
Cisen Pharmaceutical
Shandong Hualu Pharmaceutical
Reyoung Pharmaceutical

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂